Press Releases
FDA accepted Teva’s Fluticasone Propionate and Fluticasone Propionate RespiClick Inhalers
Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has accepted for review the company’s new drug applications (NDAs) for two products for adolescent...
Press Releases
Teva and Antares Pharma Announce Launch of Generic Imitrex in the United States
Teva Pharmaceutical Industries Ltd and Antares Pharma, Inc. announced the launch of the generic equivalent to Imitrex®1 (sumatriptan succinate) injection, 4 mg and 6...
News
Pfizer plans to Investment $350M in a New World-Class Global Biotechnology Center in China
Pfizer Inc announced that it will invest approximately USD$350 million in the development of a state-of-the-art Global Biotechnology Center at a ground-breaking ceremony in...
Articles
Fighting Cancer with targeted Drugs
“Diagnosis cancer” – this is a life-changing moment for many people. After cardiovascular diseases, cancer remains the next most common cause of death worldwide....
Articles
The Anti-Counterfeit Drug Issue; It’s Real
Legislation is being put into place, but it is still essential that we all play a participative role in the continued fight to protect...
Press Releases
Teva and Antares Pharma Announce Launch of Generic Imitrex in the United States
Teva Pharmaceutical Industries Ltd. and Antares Pharma, Inc. announced the launch of the generic equivalent to Imitrex injection, 4 mg and 6 mg single-dose,...
Press Releases
Mylan Launches Generic Version of Glaxo’s Avodart in U.S
Mylan N.V. announced the U.S. launch of Dutasteride Capsules, 0.5 mg, the generic version of GlaxoSmithKline's Avodart® Capsules. Mylan received final approval from the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read